Bronchiolitis obliterans after hematopoietic stem cell transplantation

A. Roca Noval, M. Erro, M. Hernández, C. Acosta, L. Diab, R. M. Girón

Research output: Indexed journal article Articlepeer-review


Hematopoietic stem cell transplantation is an established treatment with a high curative potential for various hematological diseases. Chronic graft-versus-host disease is a major complication of this procedure and is the leading cause of late mortality after transplantation. Bronchiolitis obliterans is a particularly serious complication that occurs in 10-15% of patients with extensive graft-versus-host disease and is often refractory to treatment. If there is no response to conventional immunosuppressive treatment after 3-6 months of treatment, the prognosis of these patients is unfortunate. We report the case of a 57 year old woman diagnosed with a chronic T lymphoproliferative syndrome who developed bronchiolitis obliterans one year after an hematopoietic stem cell transplantation.

Translated title of the contributionBronquiolitis obliterante tras trasplante de progenitores hematopoyéticos
Original languageEnglish
Pages (from-to)97-100
Number of pages4
JournalRevista de Patologia Respiratoria
Issue number3
Publication statusPublished - 1 Jul 2017
Externally publishedYes


  • Bronchiolitis obliterans
  • Chronic graft-versus-host disease
  • Hematopoietic stem cell transplantation


Dive into the research topics of 'Bronchiolitis obliterans after hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

Cite this